
TY  - JOUR
TI  - Abstracts of Papers to be Presented at American Association of Blood Banks. 50 Annual Meeting October 18–22, 1997
JO  - Transfusion
VL  - 37
IS  - S9
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.1997.tb02797.x
DO  - doi:10.1111/j.1537-2995.1997.tb02797.x
SP  - 1s
EP  - 111s
PY  - 1997
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Immunology
VL  - 137
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12002
DO  - doi:10.1111/imm.12002
SP  - 185
EP  - 772
PY  - 2012
ER  - 

TY  - JOUR
C7  - e27989
TI  - SIOP ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 66
IS  - S4
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.27989
DO  - doi:10.1002/pbc.27989
SP  - e27989
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Stroke
VL  - 5
IS  - s2
SN  - 1747-4930
UR  - https://doi.org/10.1111/j.1747-4949.2010.00480.x
DO  - doi:10.1111/j.1747-4949.2010.00480.x
SP  - 1
EP  - 375
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00028.x
DO  - doi:10.1111/j.1538-7836.2007.tb00028.x
SP  - P-T-201
EP  - P-T-400
PY  - 2007
ER  - 

TY  - JOUR
TI  - ABSTRACTS – Online Panel Discussion (i-Pos)
JO  - International Journal of Rheumatic Diseases
VL  - 11
IS  - s1
SN  - 1756-1841
UR  - https://doi.org/10.1111/j.1479-8077.2008.00373.x
DO  - doi:10.1111/j.1479-8077.2008.00373.x
SP  - A84
EP  - A514
PY  - 2008
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Journal of Clinical Periodontology
VL  - 30
IS  - s4
SN  - 0303-6979
UR  - https://doi.org/10.1034/j.1600-051X.30.s4.5.x
DO  - doi:10.1034/j.1600-051X.30.s4.5.x
SP  - 19
EP  - 100
PY  - 2003
ER  - 

TY  - JOUR
TI  - Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 26
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12210
DO  - doi:10.1111/tri.12210
SP  - 1
EP  - 184
PY  - 2013
ER  - 

AU  - Morgan, Shanna
AU  - McCullough, Jeffrey
C7  - pp. 388-406
TI  - Therapeutic apheresis
SN  - 9781119012993
UR  - https://doi.org/10.1002/9781119013020.ch33
DO  - doi:10.1002/9781119013020.ch33
SP  - 388-406
KW  - coagulopathy
KW  - hyperviscosity
KW  - immunoglobulin
KW  - nonplasma replacement solutions
KW  - plasma exchange
KW  - renal failure
KW  - therapeutic apheresis
PY  - 2013
AB  - Summary Therapeutic apheresis is one of the few areas of Transfusion Medicine involving direct patient care. This can involve exchange transfusions of plasma or red cells, therapeutic cytoreduction in clinical situations with abnormal accumulations of blood cells, usually myeloid or platelets, selective removal of offending molecules such as lipoproteins, or treatment of mononuclear cells with photochemical technology to treat immune diseases. Plasma exchange is used in a variety of immune diseases while red cell exchange is almost exclusively done in patients with sickle cell disease. The mechanism of action of photopheresis in not well understood but it is used in one lymphoid malignance, graft rejection and GVHD. The processes of therapeutic apheresis can be complex especially since some of the patients are quite ill. This chapter reviews the techniques and the clinical use of these procedures.
ER  - 

TY  - JOUR
TI  - Abstracts of papers: American Association of Blood Banks, 41st annual meeting. October 8–13, 1988, Kansas City, Missouri
JO  - Transfusion
VL  - 28
IS  - S6
SN  - 9781119012993
UR  - https://doi.org/10.1046/j.1537-2995.28.6s.1.x
DO  - doi:10.1046/j.1537-2995.28.6s.1.x
SP  - 4S
EP  - 68S
PY  - 1988
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Journal of Gastroenterology and Hepatology
VL  - 26
IS  - s5
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1440-1746.2011.06898.x
DO  - doi:10.1111/j.1440-1746.2011.06898.x
SP  - 16
EP  - 288
PY  - 2011
ER  - 

TY  - JOUR
AU  - Warkentin, Theodore E.
TI  - HITlights: A career perspective on heparin-induced thrombocytopenia
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 87
IS  - S1
SN  - 9781119012993
UR  - https://doi.org/10.1002/ajh.23127
DO  - doi:10.1002/ajh.23127
SP  - S92
EP  - S99
PY  - 2012
AB  - Abstract Two decades of research into heparin-induced thrombocytopenia (HIT) permit a personal historical perspective on this fascinating syndrome. Previously, the frequency of HIT was unknown, although complicating thrombosis was believed to be rare and primarily arterial. The opportunity to apply a remarkable test for ?HIT antibodies??the 14C-serotonin-release assay (SRA)?to serial plasma samples obtained during a clinical trial of heparin thromboprophylaxis, provided insights into the peculiar nature of HIT, such as, its prothrombotic nature?including its strong association with venous thrombosis (RR = 11.6 [95%CI, 6.4?20.8; P < 0.0001); its more frequent occurrence with unfractionated versus low-molecular-weight heparin; the ?iceberg? model, which states that among the many patients who form anti-PF4/heparin antibodies during heparin therapy, only a minority whose antibodies evince strong platelet-activating properties develop HIT; and the characteristic HIT timeline, whereby serum/plasma antibodies are readily detectable at or prior to the HIT-associated platelet count fall. Applying the SRA also to patients encountered in clinical practice led to recognition of warfarin-induced venous limb gangrene (for which HIT is a major risk factor via its extreme hypercoagulability) and delayed-onset HIT (whereby thrombocytopenia begins or worsens following heparin discontinuation, due to the ability of HIT antibodies strongly to activate platelets even in the absence of heparin?so-called heparin-?independent? platelet activation). Recent concepts include the increasing recognition of HIT ?overdiagnosis? (due to the low diagnostic specificity of the widely-applied PF4-dependent immunoassays), and the observation that HIT-associated consumptive coagulopathy is a risk factor for treatment failure with PTT-adjusted direct thrombin inhibitor therapy (?PTT confounding? secondary to HIT-associated coagulopathy). Am. J. Hematol. 2012. ? 2012 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - Abstracts of papers presented at the 27th Annual Meeting of the American Society of Dermatopathology
JO  - Journal of Cutaneous Pathology
VL  - 16
IS  - 5
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1600-0560.1989.tb00057.x
DO  - doi:10.1111/j.1600-0560.1989.tb00057.x
SP  - 291
EP  - 331
PY  - 1989
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Mycoses
VL  - 55
IS  - s4
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1439-0507.2012.02206.x
DO  - doi:10.1111/j.1439-0507.2012.02206.x
SP  - 95
EP  - 338
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Mycoses
JA  - Mycoses
VL  - 58
IS  - S4
SN  - 9781119012993
UR  - https://doi.org/10.1111/myc.12380
DO  - doi:10.1111/myc.12380
SP  - 51
EP  - 226
PY  - 2015
ER  - 

TY  - JOUR
TI  - Summaries of Papers
JO  - British Journal of Dermatology
VL  - 131
IS  - s44
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1365-2133.1994.tb16140.x
DO  - doi:10.1111/j.1365-2133.1994.tb16140.x
SP  - 14
EP  - 29
PY  - 1994
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
VL  - 40
IS  - s1
SN  - 9781119012993
UR  - https://doi.org/10.1111/j.1365-2362.2009.02245.x
DO  - doi:10.1111/j.1365-2362.2009.02245.x
SP  - 24
EP  - 91
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 169
IS  - s1
SN  - 9781119012993
UR  - https://doi.org/10.1111/bjh.13350
DO  - doi:10.1111/bjh.13350
SP  - 1
EP  - 104
PY  - 2015
ER  - 

TY  - JOUR
AU  - Liong, Rebecca W.
AU  - Salonga-Reyes, Armi
AU  - Morris, Sharon
TI  - Hypocomplementaemic urticarial vasculitis syndrome presenting as unilateral dacryoadenitis
JO  - Clinical & Experimental Ophthalmology
JA  - Clin Experiment Ophthalmol
VL  - 47
IS  - 8
SN  - 9781119012993
UR  - https://doi.org/10.1111/ceo.13600
DO  - doi:10.1111/ceo.13600
SP  - 1097
EP  - 1101
PY  - 2019
ER  - 

TY  - JOUR
TI  - E-Posters
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 104
IS  - S6
SN  - 9781119012993
UR  - https://doi.org/10.1002/bjs.10634
DO  - doi:10.1002/bjs.10634
SP  - 83
EP  - 243
PY  - 2017
ER  - 
